Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation Strategies

Adrien Laville,Kanta Ka,Radouane El-Ayachi,Samir Achkar,Sophie Bockel,Sébastien Gouy,Sophie Espenel,Philippe Morice,Roger Sun,Patricia Pautier,Cyrus Chargari

International journal of radiation oncology, biology, physics（2024）

引用 0|浏览11

暂无评分

摘要

IGABT permits dose escalation and high LC rates for cervical cancer patients with extrapelvic extension. Dose/effect relationships for survival were shown. Because of high frequency of distant events, systemic intensification should be tested more specifically among these patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要